JP2025165933A5 - - Google Patents

Info

Publication number
JP2025165933A5
JP2025165933A5 JP2025114666A JP2025114666A JP2025165933A5 JP 2025165933 A5 JP2025165933 A5 JP 2025165933A5 JP 2025114666 A JP2025114666 A JP 2025114666A JP 2025114666 A JP2025114666 A JP 2025114666A JP 2025165933 A5 JP2025165933 A5 JP 2025165933A5
Authority
JP
Japan
Prior art keywords
dihydrate
salt
salcardin
diffraction pattern
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025114666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025165933A (ja
Filing date
Publication date
Priority claimed from JP2021542541A external-priority patent/JP2022518906A/ja
Application filed filed Critical
Publication of JP2025165933A publication Critical patent/JP2025165933A/ja
Publication of JP2025165933A5 publication Critical patent/JP2025165933A5/ja
Pending legal-status Critical Current

Links

JP2025114666A 2019-01-29 2025-07-07 サルカルディン塩 Pending JP2025165933A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962798467P 2019-01-29 2019-01-29
US62/798,467 2019-01-29
US202062959687P 2020-01-10 2020-01-10
US62/959,687 2020-01-10
JP2021542541A JP2022518906A (ja) 2019-01-29 2020-01-28 サルカルディン塩
PCT/US2020/015370 WO2020159959A1 (en) 2019-01-29 2020-01-28 Sulcardine salts
JP2023188791A JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023188791A Division JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩

Publications (2)

Publication Number Publication Date
JP2025165933A JP2025165933A (ja) 2025-11-05
JP2025165933A5 true JP2025165933A5 (https=) 2026-01-06

Family

ID=69724142

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021542541A Pending JP2022518906A (ja) 2019-01-29 2020-01-28 サルカルディン塩
JP2023188791A Pending JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩
JP2025114666A Pending JP2025165933A (ja) 2019-01-29 2025-07-07 サルカルディン塩

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2021542541A Pending JP2022518906A (ja) 2019-01-29 2020-01-28 サルカルディン塩
JP2023188791A Pending JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩

Country Status (16)

Country Link
US (3) US11426382B2 (https=)
EP (1) EP3917921A1 (https=)
JP (3) JP2022518906A (https=)
KR (2) KR102405199B1 (https=)
CN (2) CN115385871A (https=)
AU (1) AU2020216925B2 (https=)
BR (1) BR112021014640A8 (https=)
CA (1) CA3128152A1 (https=)
CL (1) CL2021001968A1 (https=)
CO (1) CO2021011042A2 (https=)
IL (1) IL285184B2 (https=)
MX (2) MX2021009033A (https=)
PH (1) PH12021551818A1 (https=)
SG (1) SG11202108160YA (https=)
WO (1) WO2020159959A1 (https=)
ZA (2) ZA202105344B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) * 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐
CA3182015A1 (en) 2020-06-12 2021-12-16 Gary Elliott Sulcardine administration for treatment of acute atrial fibrillation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1299813C (zh) 2004-12-28 2007-02-14 华南理工大学 自动撕膜落料及多样性搅拌的机构和控制装置
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
CN102665714A (zh) 2009-11-17 2012-09-12 沪亚生物国际有限责任公司 心房纤颤的治疗
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
MA41599A (fr) * 2015-02-26 2018-01-02 Array Biopharma Inc Formes cristallines d'un composé pyrrolopyridine
CA3254279A1 (en) 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
CA3023278C (en) 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
CA3054403A1 (en) * 2017-02-24 2018-08-30 Gilead Sciences, Inc. Inhibitors of bruton's tyrosine kinase
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐

Similar Documents

Publication Publication Date Title
JP2025165933A5 (https=)
JP2020511467A5 (https=)
JP2024133475A5 (https=)
JP2014527042A5 (https=)
IL214086A (en) Malt salt of n- {4 - {[7,6- bis (methyllaxy) quinoline-4-yl] oxy} phenyl) - n- (4-fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms for cancer treatment
JP2023002516A5 (https=)
JPWO2021105117A5 (https=)
JP2022502500A5 (https=)
JP2023109937A5 (https=)
JP2023027066A5 (https=)
JP2010518061A5 (https=)
PE20081157A1 (es) Forma cristalina de hemifumarato de alisquireno
JP2015522037A5 (https=)
JP2021530554A5 (https=)
JP2020528913A5 (https=)
RU2020111019A (ru) Полиморфная форма tg02
HUP9701777A2 (hu) Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására
JPWO2020051538A5 (https=)
Kohri et al. Clinical Note: Bilateral Parotid Enlargement (“Iodide Mumps”) Following Excretory Urography
JPWO2020159959A5 (https=)
CA2437994A1 (en) Crystalline forms of pyrimidine nucleoside derivative
RU2007104176A (ru) Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов
BRPI0808369A2 (pt) Sal de estrôncio de atorvastatina e composição farmacêutica compreendendo o mesmo
CN112823795A (zh) 一种特发性肺纤维化药物组合及其应用
JPWO2021026247A5 (https=)